Skip to Main Content

Paper Details

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.
Eur Urol
337
2015
ATM, Cisplatin, DNA Repair Genes, DNA repair genes, DNA repair-associated genes, FANCC, MIBC, Muscle-invasive Bladder Cancer, NAC, PARTICIPANTS, PATIENT, Patients, RB1, cancer, cancer-related genes, cisplatin, coding exons, cystectomy, muscle-invasive bladder cancer, patients, tumor, tumor tissue, tumors
Author NameAffiliation
Roland L DunbrackFox Chase Cancer Center
Michael SlifkerFox Chase Cancer Center
Roman YelenskyFoundation Medicine Inc.
David J McConkeyMD Anderson Cancer Center
Vincent A MillerFoundation Medicine Inc.
Erica A GolemisFox Chase Cancer Center
  • 1 - 6

Datasets

Release 1.2